Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 299 M312 M287 M292 M283 M 1.17 B Research & development ————— — Operating income 669 M778 M476 M-76 M711 M 1.89 B Non-Operating Income, Total 23 M5 M9 M9 M4 M 27 M Interest expense, net of interest capitalized 143 M94 M92 M78 M94 M 358 M Non-Operating Income, excl. Interest Expenses -121 M-89 M-85 M-70 M-89 M -333 M Unusual income/expense 1 M02 M1 M-1 M 2 M Pretax income 550 M693 M398 M-145 M622 M 1.57 B Equity in earnings 1 M4 M6 M01 M 11 M Taxes 122 M150 M82 M-27 M146 M 351 M Non-controlling/minority interest -1 M-2 M0-2 M-2 M -6 M After tax other income/expense -24 M-23 M-57 M-26 M-46 M -152 M Net income before discontinued operations 429 M545 M317 M-116 M478 M 1.22 B Discontinued operations ————— — Net income 429 M545 M317 M-116 M478 M 1.22 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 429 M545 M298 M-116 M478 M 1.21 B Basic earnings per share (Basic EPS) 0.780.990.57-0.210.87 2.22 Diluted earnings per share (Diluted EPS) 0.780.980.58-0.210.86 2.21 Average basic shares outstanding 553.1 M553.1 M553.1 M553.2 M552.5 M — Diluted shares outstanding 553.1 M553.9 M553.6 M553.2 M553.6 M — EBITDA 925 M1.05 B693 M-118 M672 M 2.29 B EBIT 743 M856 M495 M-316 M455 M 1.49 B Cost of revenue 2.25 B2.59 B2.08 B1.97 B2.5 B 9.14 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 182 M192 M198 M198 M217 M 805 M